Tag: Prescription Drugs
Risk for Hydroxychloroquine Retinopathy 8.6 Percent at 15 Years
Cumulative incidence of retinopathy was higher with increasing dose of hydroxychloroquine
Posoleucel Efficacious for Stem Cell Transplant Recipients
Posoleucel effective for refractory viral infections/disease, with overall response rate of 95 percent six weeks after treatment
Fluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19
No difference seen for fluvoxamine, placebo in composite outcome of hospitalization, urgent care visit, emergency department visit, death
Antipsychotics Increasingly Being Prescribed to Children
Period prevalence of all antipsychotic prescriptions increased 3.3 percent per year from 2000 to 2019
Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis
Long-term benefits seen in patients with inadequate response/intolerance to biologic or conventional disease-modifying antirheumatic drugs
Racial/Ethnic Minorities Less Likely to Use Newer Antiseizure Meds
Odds of being on newer ASMs increased for those who saw a neurologist, were newly diagnosed with epilepsy
Letter Intervention Ups Prescription Monitoring Program Engagement
Letters highlighting mandate to check PMP before prescribing can increase PMP search rates and PMP account-holding rates
Prenatal Exposure to Acid-Suppressive Meds Not Linked to Allergic Disease
Association seen between infant exposure to acid-suppressive medications and increased asthma risk in offspring
Cognitive Behavioral Intervention Ups ART Adherence in Adolescents, Young Adults
Improvement in self-reported antiretroviral therapy adherence and decrease in viral load seen with intervention
UGN-101 Reviewed in Real-World Upper Tract Urothelial Cancer Setting
For patients with low-grade residual disease, complete response rate was 70 percent with UGN-101
